INVO Fertility, Inc. 8-K

What Happened

• On April 23, 2026, INVO Fertility, Inc. (NASDAQ: IVF) received a letter from the Nasdaq Listing Qualifications staff stating the company did not timely file its Annual Report on Form 10‑K for the year ended December 31, 2025 and therefore does not satisfy Nasdaq Listing Rule 5250(c)(1).
• The notice has no immediate effect on the listing and the company’s shares continue to trade on The Nasdaq Capital Market under the symbol “IVF.” The company says it expects to file the 2025 Form 10‑K as soon as practicable.
• The company issued a press release on April 29, 2026 announcing receipt of the Nasdaq letter (filed as Exhibit 99.1).

Key Details

• Nasdaq letter date: April 23, 2026. Press release: April 29, 2026.
• Company has 60 calendar days from the letter date to submit a plan to regain compliance.
• If Nasdaq accepts the plan, it may grant an exception extending the deadline up to 180 days from the filing due date — effectively until October 13, 2026.
• Trading status: common stock remains listed and trading on Nasdaq (symbol IVF) while the process proceeds.

Why It Matters

• A late Form 10‑K can lead to delisting proceedings if not resolved; the 60‑day plan window and possible extension to October 13, 2026 are the company’s opportunity to avoid delisting.
• Investors should monitor the company’s filings and news for the actual 10‑K filing or any updates on Nasdaq’s acceptance of a compliance plan, as unresolved noncompliance can affect liquidity, investor confidence and access to capital.